Cécile Charles

1.2k total citations
43 papers, 380 citations indexed

About

Cécile Charles is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Cécile Charles has authored 43 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in General Health Professions. Recurrent topics in Cécile Charles's work include Cancer survivorship and care (18 papers), Cancer-related cognitive impairment studies (9 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Cécile Charles is often cited by papers focused on Cancer survivorship and care (18 papers), Cancer-related cognitive impairment studies (9 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Cécile Charles collaborates with scholars based in France, Canada and United States. Cécile Charles's co-authors include Sarah Dauchy, Émilie Lanoy, Caroline Robert, Michèle Verschoore, Christina Mateus, V. Sibaud, Robert Baran, Serge Sultan, Suzette Delaloge and S. Dauchy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Cécile Charles

37 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Charles France 12 197 85 78 72 67 43 380
Karina L. Vivar United States 9 95 0.5× 88 1.0× 35 0.4× 27 0.4× 58 0.9× 18 381
Varun Shahi United States 10 60 0.3× 86 1.0× 30 0.4× 25 0.3× 73 1.1× 16 319
Marco Antônio de Oliveira Brazil 14 232 1.2× 17 0.2× 51 0.7× 90 1.3× 46 0.7× 52 688
Jonathan Roberts United Kingdom 9 231 1.2× 9 0.1× 55 0.7× 32 0.4× 52 0.8× 15 446
Fatma Gökşin Cihan Türkiye 11 52 0.3× 36 0.4× 22 0.3× 53 0.7× 44 0.7× 35 308
Wai Ka Hung China 10 141 0.7× 9 0.1× 72 0.9× 50 0.7× 17 0.3× 14 421
Andrew Yaworsky United States 9 30 0.2× 29 0.3× 50 0.6× 32 0.4× 31 0.5× 31 313
Rita K. Munn United States 8 185 0.9× 11 0.1× 29 0.4× 60 0.8× 145 2.2× 10 667
Johnson Je United States 9 124 0.6× 10 0.1× 85 1.1× 48 0.7× 21 0.3× 35 402
Jean-Claude Manderscheid France 7 229 1.2× 91 1.1× 7 0.1× 118 1.6× 102 1.5× 19 534

Countries citing papers authored by Cécile Charles

Since Specialization
Citations

This map shows the geographic impact of Cécile Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Charles more than expected).

Fields of papers citing papers by Cécile Charles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Charles. The network helps show where Cécile Charles may publish in the future.

Co-authorship network of co-authors of Cécile Charles

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Charles. A scholar is included among the top collaborators of Cécile Charles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Charles. Cécile Charles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Lange, Marie, et al.. (2023). Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study. Journal of Cancer Survivorship. 18(6). 1974–1997. 9 indexed citations
4.
Licaj, Idlir, Elodie Coquan, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2023). Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer. 129(7). 1085–1095. 4 indexed citations
6.
Vaz-Luís, Inês, Antonio Di Meglio, Élise Martin, et al.. (2023). 2031O Randomized trial of a telephone-based weight loss intervention in overweight and obese patients (pts) with breast cancer (BC): The MEDEA trial. Annals of Oncology. 34. S1078–S1078.
7.
Martin, Élise, Antonio Di Meglio, Cécile Charles, et al.. (2021). Use of mHealth to Increase Physical Activity Among Breast Cancer Survivors With Fatigue: Qualitative Exploration. JMIR Cancer. 7(1). e23927–e23927. 14 indexed citations
8.
Saghatchian, Mahasti, Benjamin Lacas, Cécile Charles, et al.. (2021). BEAUTY and the breast: is adjuvant chemotherapy the right time for a beauty boost? Lessons learned from a large randomized controlled trial. Quality of Life Research. 31(3). 723–732. 1 indexed citations
9.
Havas, Julie, Arnauld Gbenou, Élise Martin, et al.. (2021). Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue. Breast Cancer Research and Treatment. 190(3). 517–529. 11 indexed citations
10.
Charles, Cécile, Antonio Di Meglio, Mónica Arnedos, et al.. (2021). QualFatigue study: which factors influence the use of specific interventions for breast cancer survivors with fatigue? A cross-sectional exploratory study. Supportive Care in Cancer. 29(8). 4827–4834. 3 indexed citations
11.
Charles, Cécile, Léonor Fasse, Kristopher Lamore, et al.. (2021). Feasibility of a video-based cognitive behavioral therapy for insomnia in French adult cancer outpatients: results from the Sleep-4-All-1 study. Supportive Care in Cancer. 29(10). 5883–5894. 5 indexed citations
12.
Meglio, Antonio Di, Cécile Charles, Élise Martin, et al.. (2020). 183O Use of physical activity (PA) and supportive care (SC) among patients (pts) with early breast cancer (BC) reporting cancer-related fatigue (CRF). Annals of Oncology. 31. S83–S83. 1 indexed citations
14.
Vaz-Luís, Inês, Antonio Di Meglio, Mayssam El-Mouhebb, et al.. (2018). Breast cancer (BC) related fatigue: A longitudinal investigation of its prevalence, domains and correlates. Annals of Oncology. 29. viii605–viii605. 3 indexed citations
15.
Dauchy, Sarah, et al.. (2018). Le refus de soins chez un patient adulte atteint de cancer : recommandations de prise en charge de l’AFSOS et de la SFPO. Bulletin du Cancer. 105(3). 234–244. 1 indexed citations
16.
Dauchy, Sarah, Enrica Bentivegna, Sébastien Gouy, et al.. (2015). Laparoendoscopic Single-site Surgery (LESS) for Prophylactic Salpingo-oophorectomy Improves Cosmetic Satisfaction Compared to Standard Laparoscopy.. PubMed. 35(11). 6105–10. 2 indexed citations
18.
Robert, Caroline, V. Sibaud, Christina Mateus, et al.. (2015). Nail toxicities induced by systemic anticancer treatments. The Lancet Oncology. 16(4). e181–e189. 98 indexed citations
19.
Charles, Cécile, Sarah Dauchy, & Catherine Bungener. (2013). Choix thérapeutiques : s’appuyer davantage sur les représentations individuelles des traitements. Bulletin du Cancer. 100(10). 999–1005. 3 indexed citations
20.
Charles, Cécile & Sarah Dauchy. (2011). Étudier l’image du corps en oncologie : un point sur la méthodologie de recherche. Bulletin du Cancer. 98(10). 1209–1220. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026